Screener examples › Short Sellers & Contrarian
Unprofitable stocks after huge rallies
Possible speculative overextension, with substantial squeeze risk.
“US companies over $1B with negative net income, negative free cash flow, 3-month return above 40% and RSI above 70”
Run this screen live and refine it in plain English (free, no sign-up).
US operating companies over $1B with losses, negative free cash flow, 3-month gains above 40% and RSI above 70.
Filters: Market cap > $1B; Net income (TTM) < 0; Free cash flow (TTM) < 0; 3-month return > 40%; RSI (14) > 70
Top matches on data as of November 6, 2026
| Symbol | Company | Sector | Market Cap (USD) | Net Income TTM | FCF (TTM) | 3M Return | RSI 14 | Price | Currency |
|---|---|---|---|---|---|---|---|---|---|
| XNCR | Xencor, Inc. | Healthcare | $2.7B | $-117.9M | $-176.4M | 65.7% | 76.73 | $35.75 | USD |
| REPL | Replimune Group, Inc. | Healthcare | $2.0B | $-313.9M | $-284.6M | 58.2% | 79.9 | $21.62 | USD |
| SGP | SpyGlass Pharma, Inc. Common Stock | Healthcare | $1.2B | $-56.1M | $-49.7M | 46.8% | 79.82 | $36.95 | USD |
3 matches. Research data, not investment advice.